| Effects of therapeutic beta blockade on myocardial function and cardiac remodelling in congenital cardiac disease. | |
| | |
MedLine Citation:
|
PMID: 12691286 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Cardiac remodelling is now recognised as an important aspect of cardiovascular disease progression and is, therefore, emerging as a therapeutic target in cardiac failure due to different etiologies. Little is known about the influence of different therapies for cardiac failure on the remodelling seen in infants with congenital cardiac disease. METHODS: During follow-up of a prospective and randomized trial, we investigated therapeutic effects on neurohormonal activation, ventricular function, and myocardial gene expression. We compared the data from 8 infants with severe congestive heart failure due to left-to-right shunts, who received digoxin and diuretics alone, to 9 infants who received additional treatment with propranolol. RESULTS: In these infants, beta-adrenergic blockade significantly reduced highly elevated levels of renin, from 284 +/- 319 microU/ml compared to 1061 +/- 769 microU/ml. Systolic ventricular function was normal in both groups, but diastolic ventricular function was improved in those receiving propranolol, indicated by significantly lower left atrial pressures, lower end-diastolic pressures, and less pronounced ventricular hypertrophy, the latter estimated by lower ratios of myocardial wall to ventricular cavity areas on average of 42%. Further hemodynamic parameters showed no significant differences between the groups, except for the lower heart rate in infants treated with propranolol. In those treated with digoxin and diuretics, there was a significant downregulation of beta2-receptor and angiotensin-2 receptor genes, and up-regulation of endothelin A receptor and connective tissue growth factor genes, that were partially prevented by additional treatment with propranolol. CONCLUSIONS: Beta-blockade is a new therapeutic approach for congestive heart failure in infants with congenital cardiac disease, producing with significant benefits on neurohormonal activation, diastolic ventricular function, and cardiac remodelling. |
| | |
Authors:
|
Reiner Buchhorn; Martin Hulpke-Wette; Wolfgang Ruschewski; Robert D Ross; Jens Fielitz; Reinhard Pregla; Roland Hetzer; Vera Regitz-Zagrosek |
Related Documents
:
|
9495866 - The enantiomer-specific kinetics and dynamics of verapamil after rapid intravenous admi... 10433496 - Inverse agonist activities of beta-adrenoceptor antagonists in rat myocardium. 874096 - Effects of propranolol on regional myocardial function, electrograms, and blood flow in... 2996726 - The influence of intrinsic sympathomimetic activity on regional left ventricular functi... 6968006 - Bypass grafts to the left anterior descending coronary artery: saphenous vein versus in... 10150136 - Stress echocardiographic techniques. an overview. |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Cardiology in the young Volume: 13 ISSN: 1047-9511 ISO Abbreviation: Cardiol Young Publication Date: 2003 Feb |
Date Detail:
|
Created Date: 2003-04-14 Completed Date: 2003-07-23 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9200019 Medline TA: Cardiol Young Country: England |
Other Details:
|
Languages: eng Pagination: 36-43 Citation Subset: IM |
Affiliation:
|
Department of Pediatric Cardiology, Georg-August-University, Göttingen, Germany. rbuchho@gwdg.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
administration & dosage* Digoxin / administration & dosage* Diuretics / administration & dosage* Dose-Response Relationship, Drug Drug Administration Schedule Drug Therapy, Combination Female Heart Defects, Congenital / complications*, diagnosis Heart Failure / drug therapy*, etiology, mortality Heart Function Tests Hemodynamics / drug effects Humans Infant Male Probability Prognosis Propranolol / administration & dosage* Prospective Studies Reference Values Risk Assessment Severity of Illness Index Statistics, Nonparametric Survival Rate Treatment Outcome Ventricular Remodeling / drug effects* |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Diuretics; 20830-75-5/Digoxin; 525-66-6/Propranolol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical profile of acute rheumatic fever in Pakistan.
Next Document: The clinical pathway for fast track recovery of school activities in children after minimally invasi...